Indication

Paroxysmal Nocturnal Haemoglobinuria

1 clinical trial

1 product

Clinical trial

Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms

Status: Completed, Estimated PCD: 2018-03-20

Product